Stock BIVI BIOVIE INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News BioVie Inc.

Equities

BIVI

US09074F2074

Market Closed - Nasdaq
Other stock markets
 01:30:00 09/05/2024 am IST 		5-day change 1st Jan Change
0.4853 USD -0.45% Intraday chart for BioVie Inc. -1.56% -61.48%
29/04 BioVie Gets up to $13.1 Million From US Defense Department to Evaluate Bezisterim for Long COVID MT
29/04 BioVie Awards up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim for the Treatment of Long COVID CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioVie Gets up to $13.1 Million From US Defense Department to Evaluate Bezisterim for Long COVID
MT
BioVie Awarded up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim (NE3107) for the Treatment of Long COVID
AQ
BioVie Awards up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim for the Treatment of Long COVID
CI
BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints
AQ
BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation
AQ
Lawsuit Notice: Investors who lost money with BioVie Inc. (NASDAQ: BIVI) shares should contact the Shareholders Foundation
PR
Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioVie Inc. of Class Action Lawsuit and Upcoming Deadlines - BIVI
PR
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioVie Inc. (BIVI)
BU
Shareholders that lost money on BioVie Inc.(BIVI) should contact Levi & Korsinsky about pending Class Action - BIVI
PR
The Gross Law Firm Notifies Shareholders of BioVie Inc. (BIVI) of a Class Action Lawsuit and an Upcoming Deadline
PR
BIVI Investors Have Opportunity to Lead BioVie Inc. Securities Fraud Lawsuit
PR
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioVie
PR
BIVI DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages BioVie Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - BIVI
PR
BIOVIE INC. CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by March 19, 2024
PR
Class Action Filed Against BioVie Inc. (BIVI) - March 19, 2024 Deadline to Join - Contact Levi & Korsinsky
PR
BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities
CI
BioVie Announces Pipeline Update and Near-Term Clinical Priorities
AQ
BioVie Inc. Class Action: The Gross Law Firm Reminds BioVie Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - BIVI
PR
ROSEN, LEADING INVESTOR COUNSEL, Encourages BioVie Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - BIVI
NE
BIVI Investors Have Opportunity to Lead BioVie Inc. Securities Fraud Lawsuit
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIVI Stock
  4. News BioVie Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW